Search results
Jun 14, 2024 · Innomar Strategies est une filiale du géant américain de la distribution de médicaments Cencora. Les données médicales et personnelles de patients d’Innomar Strategies – une importante...
Jun 14, 2024 · Medical and personal patient data from Innomar Strategies – a major Canadian pharmaceutical company – was stolen following an intrusion into the parent company’s computer system. Potential victims interviewed by La Presse did not know that this company had access to this sensitive information.
Jun 26, 2024 · Il y a deux semaines, La Presse révélait que les données médicales et personnelles de patients d’Innomar Strategies ... Cencora. À la fin d’avril, c’est la chaîne de pharmacies London ...
Jun 27, 2024 · Il y a deux semaines, La Presse révélait que les données médicales et personnelles de patients d’Innomar Strategies – important gestionnaire canadien de programmes de soins liés à des médicaments...
Jun 17, 2024 · U.S. pharmaceutical giant Cencora has been affected by a data breach. The company is notifying affected individuals that their personal and highly sensitive medical information was stolen during...
6 days ago · Cencora, Inc. ( NYSE: COR ), formerly known as AmerisourceBergen, presents a complex investment puzzle for even the savviest of investors. My discounted cash flow (DCF) suggests significant...
Jun 22, 2024 · 7 Strategies for Effective Biosimilar Transitions. Allow a minimum of 12 months for the transition, giving physicians and patients time to consider what is best for patient care. Consider outcomes and risks that may arise from substitution.
